Amphastar Pharmaceuticals
AMPH
AMPH
114 hedge funds and large institutions have $307M invested in Amphastar Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
21% less capital invested
Capital invested by funds: $388M → $307M (-$80.7M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $154K
Holders
114
Holding in Top 10
–
Calls
–
Puts
$154K
Top Buyers
| 1 | +$4.86M | |
| 2 | +$3.47M | |
| 3 | +$1.99M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.28M |
| 5 |
Goldman Sachs
New York
|
+$1.04M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$3.07M | |
| 3 | -$2.26M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.22M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$1.16M |